Prenatal screening at 11-13+6 weeks in assisted reproductive technology singleton pregnancies and those conceived naturally

Journal of Obstetrics and Gynaecology Research

Volumn 41, Issue 10, 2015, Pages 1514-1519

  Gong, Meng ^a   Shi, Hua ^a   Zhang, Yu Guo ^a   Ming, Lei ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

assisted reproductive technology; biochemical marker; chromosome abnormality; natural pregnancy; serum; ultrasound screening

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A; BIOLOGICAL MARKER;

ADULT; AMNIOCENTESIS; ARTICLE; ASSISTED REPRODUCTIVE TECHNOLOGY; BIPARIETAL DISTANCE; BODY MASS; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CONTROLLED STUDY; CROWN RUMP LENGTH; ECHOGRAPHY; FEMALE; GENETIC RISK; GESTATION PERIOD; HUMAN; INFERTILITY THERAPY; KARYOTYPE; MATERNAL AGE; PATIENT SAFETY; PREGNANT WOMAN; PRENATAL SCREENING; RISK ASSESSMENT; UNITED KINGDOM; ADVERSE EFFECTS; BLOOD; CHINA; CONGENITAL ABNORMALITIES; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; PREGNANCY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; BIOMARKERS; CHINA; CHROMOSOME ABERRATIONS; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; KARYOTYPE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 84943272953     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12752     Document Type: Article

References (21)

1. Nicolaides KH,. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 45-67.
2. Wang JX, Norman RJ, Wilcox AJ,. Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology. Hum Reprod 2004; 19: 272-277.
3. Wisborg K, Ingerslev HJ, Henriksen TB,. IVF and stillbirth: A prospective follow-up study. Hum Reprod 2010; 25: 1312-1316.
4. Zhu JL, Basso O, Obel C, et al,. Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ 2006; 333: 679.
5. Abu-Musa AA, Nassar AH, Usta IM,. Attitude of women with IVF and spontaneous pregnancies towards prenatal screening. Hum Reprod 2008; 23: 2438-2443.
6. Gjerris AC, Loft A, Pinborg A, et al,. Prenatal testing among women pregnant after assisted reproductive techniques in Denmark 1995-2000: A national cohort study. Hum Reprod 2008; 23: 1545-1552.
7. Palomaki GE, Knight GJ, Haddow JE,. Calculating amniotic fluid alpha-fetoprotein median values in the first trimester. Prenat Diagn 1993; 13: 887-889.
8. Orvos H, Wayda K, Kozinszky Z, et al,. Increased nuchal translucency and congenital heart defects in euploid fetuses. The Szeged experience Eur J Obstet Gynecol Reprod Biol 2002; 101: 124-128.
9. Nelissen EC, Van Montfoort AP, Smits LJ, et al,. IVF culture medium affects human intrauterine growth as early as the second trimester of pregnancy. Hum Reprod 2013; 28: 2067-2074.
10. Wu FS, Hwu YM, Lee RK, et al,. First trimester ultrasound estimation of gestational age in pregnancies conceived after in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 2012; 160: 151-155.
11. Anckaert E, Schiettecatte J, Sleurs E, et al,. First trimester screening for Down's syndrome after assisted reproductive technology: Non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation. Fertil Steril 2008; 90: 1206-1210.
12. Bellver J, Lara C, Soares SR, et al,. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 2005; 20: 2623-2627.
13. Bellver J, Casanova C, Garrido N, et al,. Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and the increased false-positive rates in first-trimester Down syndrome screening. Fertil Steril 2013; 100: 1314-1320.
14. Engels MA, Pajkrt E, Groot DT, et al,. Validation of correction factors for serum markers for first-trimester Down syndrome screening in singleton pregnancies conceived with assisted reproduction. Fetal Diagn Ther 2013; 34: 217-224.
15. Lambert-Messerlian G, Dugoff L, Vidaver J, et al,. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): A FASTER trial study. Prenat Diagn 2006; 26: 672-678.
16. Liao AW, Heath V, Kametas N, et al,. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001; 16: 1501-1504.
17. Maymon R, Shulman A,. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 2004; 24: 125-129.
18. Hui PW, Tang MH, Lam YH, et al,. Nuchal translucency in pregnancies conceived after assisted reproduction technology. Ultrasound Obstet Gynecol 2005; 25: 234-238.
19. Benacerraf BR, Frigoletto FD Jr, Laboda LA,. Sonographic diagnosis of Down syndrome in the second trimester. Am J Obstet Gynecol 1985; 153: 49-52.
20. Shaw GM, Wise PH, Mayo J, et al,. Maternal prepregnancy body mass index and risk of spontaneous preterm birth. Paediatr Perinat Epidemiol 2014; 28: 302-311.
21. Werner M, Reh A, Grifo J, et al,. Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile population. J Assist Reprod Genet 2012; 29: 817-820.